Addex Average Assets vs Average Equity Analysis

ADXN Stock  USD 12.35  0.30  2.49%   
Trend analysis of Addex Therapeutics balance sheet accounts such as Short Long Term Debt Total of 461.9 K, Other Current Liabilities of 1.5 M or Total Current Liabilities of 4.1 M provides information on Addex Therapeutics' total assets, liabilities, and equity, which is the actual value of Addex Therapeutics to its prevalent stockholders. By breaking down trends over time using Addex Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.

About Addex Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Addex Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Addex Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Addex Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Addex currently owns. An asset can also be divided into two categories, current and non-current.

Addex Therapeutics Balance Sheet Chart

Addex Therapeutics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Addex Therapeutics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Addex Therapeutics' Total Liabilities is very stable compared to the past year. As of the 28th of March 2024, Intangible Assets is likely to grow to about 30.8 M, while Total Assets are likely to drop about 7.1 M.

Total Assets

Total assets refers to the total amount of Addex Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Addex Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Addex Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Addex Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Addex Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Addex Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.As of the 28th of March 2024, Selling General Administrative is likely to drop to about 4.3 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 1.5 M

Addex Therapeutics fundamental ratios Correlations

-0.310.530.680.990.71-0.11-0.990.540.570.990.540.070.99-0.07-0.28-0.33-0.410.670.310.990.06-0.170.30.440.4
-0.310.06-0.09-0.36-0.46-0.10.31-0.6-0.49-0.3-0.230.22-0.30.04-0.09-0.310.520.03-0.6-0.31-0.250.070.340.38-0.45
0.530.060.880.460.79-0.26-0.450.240.00.450.80.50.45-0.26-0.29-0.12-0.030.810.480.47-0.14-0.4-0.110.290.64
0.68-0.090.880.590.750.13-0.620.180.410.620.650.260.620.07-0.030.01-0.040.970.570.640.24-0.120.080.510.5
0.99-0.360.460.590.68-0.14-0.990.580.560.990.50.030.99-0.1-0.29-0.34-0.460.580.270.990.02-0.170.280.360.38
0.71-0.460.790.750.68-0.33-0.630.730.220.630.90.380.63-0.44-0.45-0.19-0.540.650.530.64-0.13-0.52-0.220.110.76
-0.11-0.1-0.260.13-0.14-0.330.04-0.540.57-0.04-0.55-0.66-0.040.890.830.570.480.210.29-0.050.880.860.280.31-0.41
-0.990.31-0.45-0.62-0.99-0.630.04-0.49-0.6-1.0-0.430.04-1.0-0.010.20.290.37-0.63-0.27-1.0-0.110.07-0.33-0.43-0.3
0.54-0.60.240.180.580.73-0.54-0.490.130.490.650.260.49-0.69-0.68-0.41-0.880.080.10.5-0.37-0.62-0.27-0.20.55
0.57-0.490.00.410.560.220.57-0.60.130.610.0-0.330.610.450.310.08-0.140.450.440.610.690.330.430.430.03
0.99-0.30.450.620.990.63-0.04-1.00.490.610.43-0.041.00.0-0.23-0.32-0.380.630.261.00.11-0.080.350.450.3
0.54-0.230.80.650.50.9-0.55-0.430.650.00.430.750.43-0.6-0.58-0.28-0.470.560.360.45-0.35-0.73-0.290.070.81
0.070.220.50.260.030.38-0.660.040.26-0.33-0.040.75-0.04-0.59-0.53-0.31-0.180.21-0.04-0.02-0.53-0.76-0.27-0.020.55
0.99-0.30.450.620.990.63-0.04-1.00.490.611.00.43-0.040.0-0.22-0.32-0.380.630.261.00.11-0.080.350.450.3
-0.070.04-0.260.07-0.1-0.440.89-0.01-0.690.450.0-0.6-0.590.00.940.640.650.160.26-0.010.790.840.320.29-0.44
-0.28-0.09-0.29-0.03-0.29-0.450.830.2-0.680.31-0.23-0.58-0.53-0.220.940.850.67-0.010.37-0.230.710.780.03-0.02-0.32
-0.33-0.31-0.120.01-0.34-0.190.570.29-0.410.08-0.32-0.28-0.31-0.320.640.850.53-0.080.5-0.320.460.49-0.49-0.420.03
-0.410.52-0.03-0.04-0.46-0.540.480.37-0.88-0.14-0.38-0.47-0.18-0.380.650.670.530.010.06-0.380.380.550.050.1-0.33
0.670.030.810.970.580.650.21-0.630.080.450.630.560.210.630.16-0.01-0.080.010.460.640.32-0.040.280.690.35
0.31-0.60.480.570.270.530.29-0.270.10.440.260.36-0.040.260.260.370.50.060.460.280.440.07-0.16-0.030.55
0.99-0.310.470.640.990.64-0.05-1.00.50.611.00.45-0.021.0-0.01-0.23-0.32-0.380.640.280.11-0.090.350.450.32
0.06-0.25-0.140.240.02-0.130.88-0.11-0.370.690.11-0.35-0.530.110.790.710.460.380.320.440.110.580.330.44-0.26
-0.170.07-0.4-0.12-0.17-0.520.860.07-0.620.33-0.08-0.73-0.76-0.080.840.780.490.55-0.040.07-0.090.580.310.17-0.52
0.30.34-0.110.080.28-0.220.28-0.33-0.270.430.35-0.29-0.270.350.320.03-0.490.050.28-0.160.350.330.310.8-0.46
0.440.380.290.510.360.110.31-0.43-0.20.430.450.07-0.020.450.29-0.02-0.420.10.69-0.030.450.440.170.8-0.2
0.4-0.450.640.50.380.76-0.41-0.30.550.030.30.810.550.3-0.44-0.320.03-0.330.350.550.32-0.26-0.52-0.46-0.2
Click cells to compare fundamentals

Addex Therapeutics Account Relationship Matchups

Addex Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets33.0M20.2M22.5M8.3M7.5M7.1M
Other Current Liab2.0M1.5M2.1M1.7M1.5M1.5M
Total Current Liabilities5.7M3.6M4.1M3.3M3.0M4.1M
Total Stockholder Equity25.5M14.6M16.9M4.9M4.4M4.2M
Property Plant And Equipment Net571.0K633.1K542.1K398.7K358.9K340.9K
Net Debt(31.0M)(18.1M)(20.0M)(6.6M)(7.6M)(8.0M)
Retained Earnings(300.8M)(313.7M)(329.1M)(349.9M)(314.9M)(330.6M)
Accounts Payable2.2M983.5K1.8M1.3M1.1M923.5K
Cash31.5M18.7M20.5M7.0M6.3M5.9M
Non Current Assets Total639.9K692.2K600.0K453.1K407.8K387.4K
Non Currrent Assets Other68.9K59.1K57.9K54.4K48.9K46.5K
Cash And Short Term Investments31.6M18.8M20.5M7.0M6.3M6.0M
Common Stock Shares Outstanding26.4M26.7M34.1M45.2M52.0M54.6M
Liabilities And Stockholders Equity33.0M20.2M22.5M8.3M7.5M7.1M
Other Current Assets734.0K498.4K1.1M871.9M1.0B1.1B
Other Stockholder Equity286.4M286.9M272.3M327.9M377.0M284.2M
Total Liab7.5M5.6M5.6M3.4M3.0M4.6M
Property Plant And Equipment Gross571.0K633.1K4.3M4.4M4.0M2.4M
Total Current Assets32.4M19.5M21.9M7.8M7.0M6.7M
Short Term Debt373.0K308.6K287.7K286.1K329.0K181.4K
Non Current Liabilities Total1.8M2.0M1.5M87.0K100.1K95.1K
Accumulated Other Comprehensive Income7.1M8.6M24.4M25.8M29.6M31.1M
Net Receivables118.0K68.4K324.4K598.3K538.5K285.4K
Other Liab639.4K1.6M1.7M1.3M1.5M813.2K
Net Tangible Assets25.5M14.6M16.9M4.9M5.6M5.4M
Other Assets68.9K59.1K57.9K54.4K48.9K66.0K
Short Term Investments14.0K64.9K17.1K3.2K3.6K3.5K
Property Plant Equipment571.0K633.1K542.1K398.7K458.5K275.1K
Net Invested Capital25.5M14.6M16.9M4.9M4.4M4.2M
Net Working Capital26.7M15.9M17.8M4.5M4.1M3.9M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Addex Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Addex Therapeutics' short interest history, or implied volatility extrapolated from Addex Therapeutics options trading.

Pair Trading with Addex Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Addex Stock

  0.64EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against Addex Stock

  0.84MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.79CALT Calliditas Therapeutics Financial Report 21st of May 2024 PairCorr
  0.77MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.76VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.71MBRX Moleculin Biotech Upward RallyPairCorr
The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Addex Stock analysis

When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(20.05)
Revenue Per Share
3.72
Quarterly Revenue Growth
(0.21)
Return On Assets
(0.75)
Return On Equity
(1.91)
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.